SCHEMBL22320239

SCHEMBL22320239

C[CH]C(C)c1nc2ccccc2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.58
▸ HPGD P15428 3/20 0.51
▸ CASR P41180 1/20 0.50
▸ ALOX5 P09917 1/20 0.50
▸ TSHR P16473 2/20 0.47
▸ GAA P10253 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ RAB9A P51151 4/20 0.46
▸ MAPT P10636 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ PAX8 Q06710 1/20 0.45
▸ NOD2 Q9HC29 1/20 0.45
▸ HSD17B10 Q99714 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2146969 0.81 LOXL2 (0.66) LOXL2HPGDCASRALOX5TSHR
SCHEMBL62420 0.81 LOXL2 (0.66) LOXL2HPGDCASRALOX5TSHR
SCHEMBL9675088 0.79 LOXL2 (0.64) LOXL2HPGDCASRALOX5TSHR
SCHEMBL22919824 0.79 LOXL2 (0.55) LOXL2HPGDCASRALOX5TSHR
SCHEMBL21275558 0.78 LOXL2 (0.62) LOXL2HPGDCASRALOX5TSHR
SCHEMBL21318392 0.78 LOXL2 (0.62) LOXL2HPGDCASRALOX5TSHR
SCHEMBL12085830 0.78 HPGD (0.64) LOXL2HPGDCASRALOX5TSHR
SCHEMBL17947424 0.78 HPGD (0.64) LOXL2HPGDCASRALOX5TSHR
SCHEMBL20072395 0.78 LOXL2 (0.62) LOXL2HPGDCASRALOX5TSHR
SCHEMBL485998 0.78 HPGD (0.64) LOXL2HPGDCASRALOX5TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11629138-B2 Microbiocidal picolinamide derivatives SYNGENTA PARTICIPATIONS AG (CH) 2023-04-18 — — US disclosed
EP-3692029-B1 MICROBIOCIDAL PICOLINAMIDE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2023-04-12 — — EP disclosed
US-20200255400-A1 Microbiocidal Picolinamide Derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255400-A1 Microbiocidal Picolinamide Derivatives PRF1, CASP1, FPR1 LOXL2 1000/4885HPGD 1454/4885CASR 2605/4885
US-11629138-B2 Microbiocidal picolinamide derivatives PRF1, CASP1, FPR1 LOXL2 1000/4885HPGD 1454/4885CASR 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback